EconomyInternational Relations
News 13 of 27

Trump Threatens 100-200% Tariffs on Generic Drugs: India's $9.7B Pharma Exports at Risk

Target:UPSC GS-IIIMPSCSSC GATeachingPrelims HighMains HighStatic GK Link
22 Jul 2026
~2 min
Source: Indian Express
Key Data:$9.7 billion100% tariff200% tariff40% shareSun Pharma acquisition $11.8 billionFY26 outbound investment $4.08 billion
Bodies:Commerce MinistryUSFDAGTRISun Pharmaceutical IndustriesOrganon & Co.
Practice MCQs from today's news ▸
What This Article Covers

1.US President Trump threatened 100% tariff on generic drugs after two years and 200% thereafter to reshore production.

2.India's pharma exports to US stood at $9.7 billion in 2025, accounting for 40% of total pharma exports, with 90% being generics.

3.Indian pharma majors like Sun Pharma are acquiring US firms (Organon for $11.8B) and expanding US manufacturing to mitigate tariff risks.

The Big Picture
Prelims · HighMains · High

Trump's threat to impose 100-200% tariffs on generic drugs aims to reshore production in the US. This directly impacts India, which exports $9.7 billion worth of pharmaceuticals to the US annually, with 90% being generics. Indian pharma companies are responding by increasing US investments and acquisitions to secure market access.

Exam Lens

Quick Exam Facts From News

Tariff Threat100% after 2 years, 200% thereafter
India's Pharma Exports to US (2025)$9.7 billion
Share of US in India's Pharma Exports~40%
Share of Generics in India's Pharma Exports to US~90%
Sun Pharma's Acquisition of Organon$11.8 billion
Outbound Investment from India to US (FY26)$4.08 billion

1-Minute Revision

  • ›Tariff Threat: 100% after 2 years, 200% thereafter
  • ›India's Pharma Exports to US (2025): $9.7 billion
  • ›Target this Data: India's pharma exports to US in 2025: $9.7 billion
  • ›Target this Nodal Body: USFDA (approves manufacturing facilities of Indian companies in US)
  • ›Target this Legal Point: Section 232 of Trade Expansion Act 1962 (used for tariff threat)

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

Q1Static LinkageEasy

Which Indian ministry provided the data on outbound investment from India to the US in a Lok Sabha reply?

Q2Statement-basedHard

Consider the following statements:

1. Trump threatened to impose 100% tariffs on generic drugs after two years and 200% thereafter.

2. India's pharmaceutical exports to the US in 2025 were $9.7 billion, accounting for nearly 40% of India's total pharma exports.

3. Sun Pharmaceutical Industries acquired US-based Organon & Co. for $11.8 billion, the largest overseas acquisition by an Indian pharma company.

Which of the statements given above is/are correct?

Q3Data-centricMedium

What was the value of India's pharmaceutical exports to the US in 2025?

Q4Application/ImpactMedium

What is the primary objective of Trump's tariff threat on generic drugs according to the article?

All 25 MCQs ▸
You finished this topic
Explore Related Topics
Related Current Affairs
Economy Current Affairs

India's Exports to Core BRICS Surge 34% to $19.9 Billion; China Leads

India's exports to core BRICS nations (China, South Africa, Brazil, Russia) surged 34% to $19.9 billion in April-August 2026-27, with China leading at 39% growth. This highlights the bloc's growing importance in India's trade strategy, offering a counter-narrative to the usual focus on Western markets.

Intl. Relations Current Affairs

US Imposes 100% Tariff on India Pharma Exports from 2028, Impact on $150 Bn Trade

Trump's unilateral tariff actions on Indian pharmaceutical exports (100% from 2028, rising to 200%) and use of Sections 301, 232, and 338 expose the fragility of ongoing India-US trade negotiations. Despite $150 billion bilateral trade and India's surplus, no signed agreement seems safe. India should prioritize trade diversification towards the UK and EU.

Economy Current Affairs

India-U.S. Trade Pact: Exporters Urge Early Conclusion, Tariff Uncertainty Hits Orders, Trade Surplus Narrows to $33.9 Bn

The Commerce Ministry met exporters to discuss India-U.S. trade performance and market access issues amidst ongoing bilateral trade agreement (BTA) negotiations. Exporters urged early conclusion of the pact to reduce tariff uncertainties, as U.S. buyers have reduced order volumes. The meeting also flagged concerns over U.S. safeguard measures on quartz surface products.

Intl. Relations Current Affairs

EU CBAM: Carbon Border Tax on Steel Imports to Cost India €190/Tonne from Feb 2027

The EU has implemented the Carbon Border Adjustment Mechanism (CBAM), a carbon tax on imports of steel, aluminium, cement, fertilisers, hydrogen, and electricity. For India, this is primarily a steel tax—$5.4 billion of its $6.3 billion CBAM-exposed exports to the EU in 2024 were iron and steel. With Indian steel emitting 2.54 tonnes of CO2 per tonne (vs. world avg. 1.9), the tax could cut exports by 24%, and BRICS has formally opposed it as protectionist in the New Delhi Declaration.

Intl. Relations Current Affairs

BRICS New Delhi Declaration: India's Dilemma on Local Currency Trade vs. Strategic Autonomy

The BRICS New Delhi Declaration highlights India's cautious approach to local currency trade, balancing export advantages from a depreciating rupee against the risk of yuan dominance and US tariff threats. India supports local currency trade but opposes a common BRICS currency due to China's likely control.

Economy Current Affairs

Global Refinery Attacks Spike Sulphur Prices Above $1,000/Tonne; Threatens India's Phosphatic Fertiliser Supply

The energy crisis has shifted from crude oil supply to refined products. Attacks on refineries in Russia and West Asia have caused sulphur prices to skyrocket from $200 to $1,000/tonne, severely affecting India's ability to manufacture phosphatic fertilizers. This distinct crisis poses a long-term threat to India's food security and fertiliser imports even as the country enjoys surplus refining capacity.

Intl. Relations Current Affairs

India-EU FTA: Additional Preferential Steel Quota of 694,853 Tons, but CBCT Levy Applies

India secured an additional preferential steel export quota of 694,853 tons to the EU under the India-EU FTA, raising the total quota to 1.64 million tons. However, Indian steel remains subject to the EU's Carbon Border Adjustment Mechanism (CBAM), which could add costs equivalent to ~35% of value. This is a crucial trade-off for aspirants: market access vs. carbon compliance.

Intl. Relations Current Affairs

U.S. Senate Passes Bill Proposing 100% Tariffs on Russian Oil Importers; India Engaged in Talks

The U.S. Senate passed a bill proposing up to 100% tariffs on countries importing Russian oil in large quantities, potentially impacting India. India has had 'reassuring' discussions with the U.S., including on a trade deal, to mitigate the impact. This is critical for UPSC as it tests India-US trade relations, sanctions policy, and energy security.